These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16177628)

  • 1. Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation.
    Petersen SL; Sidorov IA; Russell CA; Dickmeiss E; Vindeløv LL
    Transplantation; 2005 Sep; 80(5):573-81. PubMed ID: 16177628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between interleukin-4-producing T lymphocyte frequencies and reduced risk of graft-versus-host disease.
    Imami N; Brookes PA; Lombardi G; Hakooz B; Johns M; Goldman JM; Batchelor JR; Lechler RI; Ritter MA
    Transplantation; 1998 Apr; 65(7):979-88. PubMed ID: 9565104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of limiting dilution analysis experiments for helper T lymphocyte precursor frequency determination in the context of allogeneic bone marrow transplantation.
    Russell CA; Brøndsted L; Vindeløv LL
    J Immunol Methods; 1999 May; 225(1-2):113-24. PubMed ID: 10365788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactivity, backstimulation and reproducibility in a helper T lymphocyte precursor assay.
    Russell CA; Petersen SL; Heilmann C; Madsen HO; Vindeløv LL
    J Immunol Methods; 2001 May; 251(1-2):109-21. PubMed ID: 11292487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA; Heilmann C; Madsen HO; Vindeløv LL
    Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies.
    Lachance S; Le Gouvello S; Roudot F; Kuentz M; Bernaudin F; Beaujean F; Bierling P; Cordonnier C; Farcet JP; Vernant JP
    Transplantation; 1997 Oct; 64(8):1147-52. PubMed ID: 9355832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of alloreactive anti-recipient helper T-cell precursors after allogenic bone marrow transplantation].
    Dittmer R; Benn HP; Cassens U; Schwarz K; Löliger C; Zander A; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1994; 32():272-5. PubMed ID: 9480107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation.
    Schwarer AP; Jiang YZ; Brookes PA; Barrett AJ; Batchelor JR; Goldman JM; Lechler RI
    Lancet; 1993 Jan; 341(8839):203-5. PubMed ID: 8093498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD; Chan SY; Bishop DK
    Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor helper T-cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Weston LE; Geczy AF; Farrell C
    Transplantation; 1997 Sep; 64(6):836-41. PubMed ID: 9326407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing a limiting dilution culture system for quantifying the frequency of interleukin-2-producing alloreactive T helper lymphocytes.
    Hornick PI; Brookes PA; Mason PD; Taylor KM; Yacoub MH; Rose ML; Batchelor R; Lechler RI
    Transplantation; 1997 Aug; 64(3):472-9. PubMed ID: 9275115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency of cytotoxic and helper T-lymphocyte precursors in donors with alloreactivity to recipient histocompatibility antigens. Possible use in predicting acute graft vs host disease in bone marrow transplantation].
    Cukrová V; Dolezalová L; Loudová M; Vítek A; Starý J
    Cas Lek Cesk; 1997 Feb; 136(3):80-4. PubMed ID: 9221174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine gene expression in peripheral blood mononuclear cells and alloreactivity in hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Dickmeiss E; Vindeløv LL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):48-60. PubMed ID: 16399568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.